JP2009528337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528337A5 JP2009528337A5 JP2008556849A JP2008556849A JP2009528337A5 JP 2009528337 A5 JP2009528337 A5 JP 2009528337A5 JP 2008556849 A JP2008556849 A JP 2008556849A JP 2008556849 A JP2008556849 A JP 2008556849A JP 2009528337 A5 JP2009528337 A5 JP 2009528337A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- budesonide
- ampoule
- sterile
- formoterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 claims 18
- 239000000203 mixture Substances 0.000 claims 18
- 239000003708 ampul Substances 0.000 claims 16
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims 11
- 229960004436 budesonide Drugs 0.000 claims 11
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims 9
- 229960002848 formoterol Drugs 0.000 claims 9
- 238000000034 method Methods 0.000 claims 9
- 239000006199 nebulizer Substances 0.000 claims 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 5
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 4
- 208000006673 asthma Diseases 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 4
- 229940021598 formoterol and budesonide Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000001914 filtration Methods 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000008174 sterile solution Substances 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 229910001873 dinitrogen Inorganic materials 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000012669 liquid formulation Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0604141.2A GB0604141D0 (en) | 2006-03-01 | 2006-03-01 | Nebulizer formulation |
| PCT/GB2007/000722 WO2007099329A2 (en) | 2006-03-01 | 2007-03-01 | Nebulizer formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009528337A JP2009528337A (ja) | 2009-08-06 |
| JP2009528337A5 true JP2009528337A5 (enExample) | 2010-03-04 |
Family
ID=36218946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008556849A Pending JP2009528337A (ja) | 2006-03-01 | 2007-03-01 | ネブライザー処方物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070207091A1 (enExample) |
| EP (1) | EP1988876A2 (enExample) |
| JP (1) | JP2009528337A (enExample) |
| KR (1) | KR20080098631A (enExample) |
| CN (1) | CN101394835A (enExample) |
| AU (1) | AU2007220288B2 (enExample) |
| BR (1) | BRPI0708170A2 (enExample) |
| CA (1) | CA2643761A1 (enExample) |
| GB (1) | GB0604141D0 (enExample) |
| IL (1) | IL193369A0 (enExample) |
| NO (1) | NO20083683L (enExample) |
| NZ (1) | NZ570432A (enExample) |
| WO (1) | WO2007099329A2 (enExample) |
| ZA (1) | ZA200806929B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
| GB0700380D0 (en) | 2007-01-09 | 2007-02-14 | Breath Ltd | Storage Of Ampoules |
| US20100055045A1 (en) * | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| CA2716936C (en) * | 2008-02-26 | 2018-06-05 | Elevation Pharmaceuticals, Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| AU2010258751A1 (en) * | 2009-06-09 | 2012-02-02 | Sunovion Respiratory Development Inc. | Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration |
| US20140296641A1 (en) * | 2013-03-28 | 2014-10-02 | William Randolph Warner | COMPOSITIONS, FORMULATIONS AND METHODS OF BIO-BALANCING THE pH OF STERILE HYPOTONIC, ISOTONIC SALINE AND HYPERTONIC SALINE SOLUTIONS |
| GB201416909D0 (en) * | 2014-09-25 | 2014-11-12 | Prosonix Ltd | Method of forming concentrated solution |
| CN107233311B (zh) * | 2017-06-27 | 2020-12-04 | 长风药业股份有限公司 | 一种以阿福特罗和格隆溴铵为活性成分的雾化剂及其制备方法 |
| US20190231769A1 (en) * | 2017-10-27 | 2019-08-01 | Nephron Pharmaceuticals Corporation | Tiotropium Inhalation Solution for Nebulization |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993011773A1 (en) * | 1991-12-18 | 1993-06-24 | Aktiebolaget Astra | New combination of formoterol and budesonide |
| SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US6946117B1 (en) * | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
| SE9802073D0 (sv) * | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
| US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| IT1313553B1 (it) * | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
| US20060171897A1 (en) * | 1999-12-23 | 2006-08-03 | Coifman Robert E | Methods and formulations for the efficient delivery of drugs by nebulizer |
| US6451289B2 (en) * | 2000-03-24 | 2002-09-17 | Sepracor Inc. | Albuterol formulations |
| GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
| EP1337279B1 (en) * | 2000-11-24 | 2006-06-21 | Breath Limited | Sterilisation of glucocorticosteriode suspensions |
| ITMI20010428A1 (it) * | 2001-03-02 | 2002-09-02 | Chemo Breath S A | Composizioni ad uso inalatorio a base di formoterolo |
| US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
| ATE418347T1 (de) * | 2002-02-19 | 2009-01-15 | Resolution Chemicals Ltd | Auf lösungsmitteln basierende sterilisation von steroiden |
| SE0203376D0 (sv) * | 2002-11-15 | 2002-11-15 | Astrazeneca Ab | New process |
| SE526509C2 (sv) * | 2003-06-19 | 2005-09-27 | Microdrug Ag | Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd |
| DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
| WO2005044226A2 (en) * | 2003-11-04 | 2005-05-19 | Nectar Therapeutics | Lipid formulations for spontaneous drug encapsulation |
| EP1696875A2 (en) * | 2003-12-12 | 2006-09-06 | Joseph Okpala | A method of engineering particles for use in the delivery of drugs via inhalation |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| EP1712220A1 (en) * | 2005-04-15 | 2006-10-18 | PARI GmbH Spezialisten für effektive Inhalation | Pharmaceutical aerosol composition |
-
2006
- 2006-03-01 GB GBGB0604141.2A patent/GB0604141D0/en not_active Ceased
-
2007
- 2007-03-01 JP JP2008556849A patent/JP2009528337A/ja active Pending
- 2007-03-01 KR KR1020087021305A patent/KR20080098631A/ko not_active Ceased
- 2007-03-01 BR BRPI0708170-7A patent/BRPI0708170A2/pt not_active IP Right Cessation
- 2007-03-01 CA CA002643761A patent/CA2643761A1/en not_active Abandoned
- 2007-03-01 ZA ZA200806929A patent/ZA200806929B/xx unknown
- 2007-03-01 NZ NZ570432A patent/NZ570432A/en not_active IP Right Cessation
- 2007-03-01 US US11/680,696 patent/US20070207091A1/en not_active Abandoned
- 2007-03-01 EP EP07705306A patent/EP1988876A2/en not_active Withdrawn
- 2007-03-01 WO PCT/GB2007/000722 patent/WO2007099329A2/en not_active Ceased
- 2007-03-01 AU AU2007220288A patent/AU2007220288B2/en not_active Ceased
- 2007-03-01 CN CNA2007800071772A patent/CN101394835A/zh active Pending
-
2008
- 2008-08-11 IL IL193369A patent/IL193369A0/en unknown
- 2008-08-27 NO NO20083683A patent/NO20083683L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009528337A5 (enExample) | ||
| RU2491072C2 (ru) | Композиции для лечения легочной гипертензии, вводимые путем ингаляции, и способы их применения | |
| ES2691033T3 (es) | Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios | |
| US20100196286A1 (en) | Inhalation delivery methods and devices | |
| JP2009269923A5 (enExample) | ||
| MX2013009525A (es) | Combinacion de glicopirrolato y un beta2-agonista. | |
| CN107998109A (zh) | 药物组合物 | |
| US20070276048A1 (en) | Unit dose formulations comprising an inhalable solution of albuterol | |
| RU2005108050A (ru) | Фармацевтические продукты и композиции, содержащие специфические антихолинергические средства, агонисты бета-2 и кортикостероиды | |
| JP2013542940A5 (enExample) | ||
| CN103096897A (zh) | 包含r(+)布地奈德和一种或多种支气管扩张剂的药物组合物 | |
| AU2007220288B2 (en) | Nebulizer formulation | |
| US8877740B2 (en) | Compound composition for inhalation used for treating asthma | |
| ES2371601T3 (es) | Composición para inhalación. | |
| NO332524B1 (no) | Inhalerbar losningsformulering inneholdende et tiotropiumsalt, slike preparater for anvendelse som medikament samt anvendelse av slike for fremstilling av medikament for behandling av sykdom | |
| JP2007524699A (ja) | ロフルミラストとグリコピロニウムとの組合せ物 | |
| EP1843750B1 (en) | Nebulizer formulation | |
| KR102669919B1 (ko) | 흡입용 캡슐제 및 이의 제조방법 | |
| US20160206610A1 (en) | Methods for treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or acute emesis and/or delayed emesis |